No profile data available.
Sunshine Biopharma, Inc. (SBFM) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Fort Lauderdale, United States, with about 50 full-time employees.
It reported revenue of $34.87 million for fiscal year 2024, up 44.7% from fiscal year 2023, and net income of -$5.13 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $9.42 million, up 11.6% from a year before. Its market capitalization was $1.81 million as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 5, 2026.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. 1 mRNA, a lipid nano-particle for liver cancer.
Sunshine Biopharma reported $34.87 million in revenue for fiscal year 2024, up 44.7% from $24.09 million in fiscal year 2023. In Q3 2025 revenue was $9.42 million.
$1.81 million as of October 5, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Marijuana Company of America, Inc. (MCOA), Cannabis Strategic Ventures (NUGS), Rafarma Pharmaceuticals, Inc. (RAFA), Amazonas Florestal, Ltd (AZFL).